Skip to content
BMY Bristol-Myers Squibb Co NYSE
63.82 USD -1.15% -0.74
OPEN 64.51
DAY RANGE 64.97 - 63.70
52 WEEK RANGE 81.44 - 63.70
Interactive Brokers Logotype

Buy BMY stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 134.1B
Enterprise value 164.3B
Trailing pe 18.606413
Forward pe 7.8402944
Peg ratio 7.8402944
Price to sales ttm 2.9243643
Price to book mrq 4.211429
Enterprise to revenue 3.583
Enterprise to ebitda 8.373


Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.15946001
Operating margin 0.20797001
Return on assets ttm 0.060399998
Return on equity ttm 0.23072
Income statement
Revenue ttm 45.8B
Revenue per share ttm 21.644
Quarterly revenue growth -0.027
Gross profit ttm 36.4B
Ebitda 20.5B
Net income to common ttm 7.3B
Diluted eps ttm 3.43
Quarterly earnings growth yoy 0.77
Balance sheet
Total cash mrq 9.3B
Total cash per share mrq 4.412
Total debt mrq 39.4B
Total debt to equity mrq 123.518
Current ratio mrq 1.419
Book value per share mrq 15.154
Cash flow
Operating cash flow ttm 12.2B
Levered free cash flow ttm 12.6B

Stock statistics

Shares outstanding 2.1B
Float shares 2.1B
Avg 10 volume 8.3M
Avg 30 volume 8.2M
Shares short 21.5M
Short ratio 2.68
Short percent of shares outstanding 0.010199999
Percent held by insiders 0.00071000005
Percent held by institutions 0.78619003

Stock price summary

Fifty two week low 63.7
Fifty two week high 81.44
Fifty two week change -18.223
Beta 0.431738
Day 50 ma 68.1888
Day 200 ma 71.76315

Dividends and splits

Forward annual dividend rate 2.28
Forward annual dividend yield 0.0357
Trailing annual dividend rate 2.22
Trailing annual dividend yield 0.03438662
5 year average dividend yield 3.01
Payout ratio 0.6472
Dividend date 2023-05-01
Ex dividend date 2023-04-06
Last split factor 1000000-for-951777 split
Last split date 2001-08-07

Bristol-Myers Squibb (BMY) stock price

Bristol-Myers Squibb (NYSE: BMY) is a biopharmaceutical company that discovers, develops, licenses, manufactures, markets, and distributes products in the sector. The company’s pharmaceutical products include chemically synthesized drugs and products produced from biological processes. It sells its products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies.